| #1 | | | Estambul, Turquía | | 22+ años | Inmunoterapia con Keytruda (Pembolizumab), Ultrasonido de tiroides | — | — | International Organization for Standardization, Joint Commission International |
| #2 | | | Estambul, Turquía | | 29+ años | Angiografía, Colonoscopia | — | — | Joint Commission International , International Organization for Standardization |
| #3 | | | Estambul, Turquía | | 23+ años | Inmunoterapia con Keytruda (Pembolizumab) | — | — | Turkish Medical Association, International Health Tourism Authorization Certificate |
| #4 | | | Barcelona, España | | 41+ años23,000+ tratamientos | Inmunoterapia con Keytruda (Pembolizumab), Gammagrafía | — | — | Joint Commission International , European Foundation for Quality Management |
| #5 | | | Estambul, Turquía | | 26+ años | Inmunoterapia con Keytruda (Pembolizumab), TEP/TC | — | — | International Organization for Standardization, Joint Commission International |
| #6 | | | Milán, Italia | | 57+ años8,000+ tratamientos | Biopsia Colposcopia, Gammagrafía | — | — | Scientific Institute for Research and Healthcare Accrediatation, World's Best Hospitals 2021 by Newsweek |
| #7 | | | Tel Aviv, Israel | | 39+ años34,000+ tratamientos | Inmunoterapia con Keytruda (Pembolizumab), Mamografía | — | — | World's Best Smart Hospitals 2021 by Newsweek, World's Best Hospitals 2021 by Newsweek |
| #8 | | | Estambul, Turquía | | 20+ años | Inmunoterapia con Keytruda (Pembolizumab), Mamografía | — | — | Joint Commission International , Turkish Medical Association (Türk Tabıplerı Bırliği) |
| #9 | | | Estambul, Turquía | | 24+ años | Inmunoterapia con Keytruda (Pembolizumab), Biopsia de médula ósea | — | — | International Organization for Standardization, Joint Commission International |
| #10 | | | Hamburgo, Alemania | | 30+ años | Inmunoterapia con Keytruda (Pembolizumab), Análisis extendido de sangre | — | — | International Organization for Standardization, Medical Travel Quality Alliance |